This workshop report summarizes the proceedings of Day 2 of a three-day workshop on “ Current State and Future Expectations of...
Patient-centric design for peptide delivery: Trends in routes of administration and advancement in drug delivery technologies
Utilizing peptides as therapeutic agents is considered an attractive approach for the treatment of various diseases due to their high...
Computational Modeling and Pharmacokinetics/ADMET Study of Some Arylpiperazine Derivatives as Novel Antipsychotic Agents Targeting Depression
This study focuses on Quantitative structure–activity relationship (QSAR) and in silico pharmacokinetics/ADMET predictions to investigate the structural...
Relationship between pimavanserin exposure and psychosis relapse in patients with dementia-related psychosis: clinical results and modeling analysis from the phase 3 HARMONY study
Dementia-related psychosis impacts more than 2.4 million patients;1-5 however, there are no
GastroPlus® Applications to Various Drug Delivery Routes of Administration – AAPS-VCU Student Chapter
John DiBella, Maxime LeMerdy, and Cherylann Iagatta host an Introductory GastroPlus User Session for Academic Research
Population Pharmacokinetic Analysis of Quizartinib in Healthy Volunteers and Patients With Relapsed/Refractory Acute Myeloid Leukemia.
Quizartinib is an FMS-like tyrosine kinase 3 (FLT3) inhibitor that has shown robust clinical activity in patients with FLT3-internal tandem duplication-mutated relapsed/refractory acute myeloid leukemia (AML).
Cumulative Fraction of Response for Once- and Twice-Daily Delamanid in Patients with Pulmonary Multidrug-Resistant Tuberculosis
Pharmacokinetic (PK) and pharmacodynamic (PD) analyses were conducted to determine the cumulative fraction of response (CFR) for 100 mg twice-daily (BID)
Reliance: a smarter way of regulating medical products – The IPRP survey
A survey was conducted among national regulatory authorities' members of the International Pharmaceutical Regulators Programme (IPRP) to collect and share experiences of reliance approaches.
OPCO Fireside Chat
Slides from the OPCO Fireside Chat
Setting up a simulation from scratch in Simulx
No matter how you have developed your population PK/PD or QSP model, Simulx-GUI is an intuitive, flexible and powerful application to simulate new situations and answer "what if" questions.
Simulations Plus Publishes its Inaugural Environmental, Social and Governance (ESG) Report
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals...
Effect of QTC-4-MeOBnE Treatment on Memory, Neurodegeneration, and Neurogenesis in a Streptozotocin-Induced Mouse Model of Alzheimer’s Disease
Growing evidence suggests that drugs targeting neurogenesis and myelinization could be novel therapeutic targets against Alzheimer’s disease (AD).
Modulating target engagement of small molecules via drug delivery: approaches and applications in drug discovery and development
Drug-delivery technologies for modified drug release have been in existence for decades, but their utilization has been largely limited..
Insights of Tris(2-pyridylmethyl)amine as anti-tumor agent for osteosarcoma: experimental and in silico studies
Osteosarcoma (OS) is a malignant bone tumor and its occurrence is associated with high levels of microRNAs (miRNAs) and critical protein involved on intracellular signaling pathways.
The Intestinal Efflux Transporter Inhibition Activity of Xanthones from Mangosteen Pericarp: An In Silico, In Vitro and Ex Vivo Approach
The capacity of α-mangostin (α-MG) and β-mangostin (β-MG) from mangosteen pericarp on P-glycoprotein (Pgp) in silico, in vitro...
Proving the Mode of Action of Phytotoxic Phytochemicals
Knowledge of the mode of action of an allelochemical can be valuable for several reasons, such as proving and...
Computational evaluation of endocrine activity of biocidal active substances
Exposure to endocrine disrupting chemicals is an important public health concern although only a few endocrine disruption chemicals have been identified so far.
AAPS VCU Chapter Webinar
GastroPlus applications to various drug delivery routes of administration.
Secure your 2021 Model Informed Drug Development (MIDD), PBPK or PBBM goals – Use your 2020 year-end budget today!
In 2021, we are committed to expanding our collaborations to advance the science of drug development, reduce the time and cost of research, and improve patient wellness. With this commitment, we are extending an exclusive offer for training and regulatory advice and support at 2020 rates for use next year.